339 related articles for article (PubMed ID: 35547744)
21. Genome Editing with CRISPR-Cas9: A Budding Biological Contrivance for Colorectal Carcinoma Research and its Perspective in Molecular Medicine.
Ray SK; Mukherjee S
Curr Mol Med; 2021; 21(6):462-475. PubMed ID: 33213345
[TBL] [Abstract][Full Text] [Related]
22. Erratic journey of CRISPR/Cas9 in oncology from bench-work to successful-clinical therapy.
Sarkar E; Khan A
Cancer Treat Res Commun; 2021; 27():100289. PubMed ID: 33667951
[TBL] [Abstract][Full Text] [Related]
23. Genome editing and cancer: How far has research moved forward on CRISPR/Cas9?
Mitra S; Sarker J; Mojumder A; Shibbir TB; Das R; Emran TB; Tallei TE; Nainu F; Alshahrani AM; Chidambaram K; Simal-Gandara J
Biomed Pharmacother; 2022 Jun; 150():113011. PubMed ID: 35483191
[TBL] [Abstract][Full Text] [Related]
24. CRISPR/Cas9 Platforms for Genome Editing in Plants: Developments and Applications.
Ma X; Zhu Q; Chen Y; Liu YG
Mol Plant; 2016 Jul; 9(7):961-74. PubMed ID: 27108381
[TBL] [Abstract][Full Text] [Related]
25. CRISPR/Cas9 in Cancer Immunotherapy: Animal Models and Human Clinical Trials.
Khalaf K; Janowicz K; Dyszkiewicz-Konwińska M; Hutchings G; Dompe C; Moncrieff L; Jankowski M; Machnik M; Oleksiewicz U; Kocherova I; Petitte J; Mozdziak P; Shibli JA; Iżycki D; Józkowiak M; Piotrowska-Kempisty H; Skowroński MT; Antosik P; Kempisty B
Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32796761
[TBL] [Abstract][Full Text] [Related]
26. CRISPR/Cas9-mediated genome editing in sea urchins.
Lin CY; Oulhen N; Wessel G; Su YH
Methods Cell Biol; 2019; 151():305-321. PubMed ID: 30948015
[TBL] [Abstract][Full Text] [Related]
27. Genome-wide CRISPR screens for the identification of therapeutic targets for cancer treatment.
Xue VW; Wong SCC; Cho WCS
Expert Opin Ther Targets; 2020 Nov; 24(11):1147-1158. PubMed ID: 32893711
[TBL] [Abstract][Full Text] [Related]
28. [Research progress in the third-generation genomic editing technology - CRISPR/Cas9].
Zhou Y; Zong Y; Kong X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Oct; 33(5):713-6. PubMed ID: 27577230
[TBL] [Abstract][Full Text] [Related]
29. Identification of genomic sites for CRISPR/Cas9-based genome editing in the Vitis vinifera genome.
Wang Y; Liu X; Ren C; Zhong GY; Yang L; Li S; Liang Z
BMC Plant Biol; 2016 Apr; 16():96. PubMed ID: 27098585
[TBL] [Abstract][Full Text] [Related]
30. Critical cancer vulnerabilities identified by unbiased CRISPR/Cas9 screens inform on efficient cancer Immunotherapy.
Potts MA; McDonald JA; Sutherland KD; Herold MJ
Eur J Immunol; 2020 Dec; 50(12):1871-1884. PubMed ID: 33202035
[TBL] [Abstract][Full Text] [Related]
31. Emerging Role of CRISPR/Cas9 Technology for MicroRNAs Editing in Cancer Research.
Aquino-Jarquin G
Cancer Res; 2017 Dec; 77(24):6812-6817. PubMed ID: 29208606
[TBL] [Abstract][Full Text] [Related]
32. Identification of Drug Resistance Genes Using a Pooled Lentiviral CRISPR/Cas9 Screening Approach.
Kerek EM; Cromwell CR; Hubbard BP
Methods Mol Biol; 2021; 2381():227-242. PubMed ID: 34590280
[TBL] [Abstract][Full Text] [Related]
33. Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium glutamicum.
Liu J; Wang Y; Lu Y; Zheng P; Sun J; Ma Y
Microb Cell Fact; 2017 Nov; 16(1):205. PubMed ID: 29145843
[TBL] [Abstract][Full Text] [Related]
34. Application of the CRISPR/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer.
Zhang H; Qin C; An C; Zheng X; Wen S; Chen W; Liu X; Lv Z; Yang P; Xu W; Gao W; Wu Y
Mol Cancer; 2021 Oct; 20(1):126. PubMed ID: 34598686
[TBL] [Abstract][Full Text] [Related]
35. CRISPR/Cas9; A robust technology for producing genetically engineered plants.
Farooq R; Hussain K; Nazir S; Javed MR; Masood N
Cell Mol Biol (Noisy-le-grand); 2018 Nov; 64(14):31-38. PubMed ID: 30511631
[TBL] [Abstract][Full Text] [Related]
36. The application of the CRISPR-Cas9 genome editing machinery in food and agricultural science: Current status, future perspectives, and associated challenges.
Eş I; Gavahian M; Marti-Quijal FJ; Lorenzo JM; Mousavi Khaneghah A; Tsatsanis C; Kampranis SC; Barba FJ
Biotechnol Adv; 2019; 37(3):410-421. PubMed ID: 30779952
[TBL] [Abstract][Full Text] [Related]
37. Optimized CRISPR/Cas tools for efficient germline and somatic genome engineering in Drosophila.
Port F; Chen HM; Lee T; Bullock SL
Proc Natl Acad Sci U S A; 2014 Jul; 111(29):E2967-76. PubMed ID: 25002478
[TBL] [Abstract][Full Text] [Related]
38. Discovery in CRISPR-Cas9 system.
Pan S; Zhang H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1392-1402. PubMed ID: 35232910
[TBL] [Abstract][Full Text] [Related]
39. Rapid Control of Genome Editing in Human Cells by Chemical-Inducible CRISPR-Cas Systems.
Liu KI; Ramli MNB; Sutrisnoh NB; Tan MH
Methods Mol Biol; 2018; 1772():267-288. PubMed ID: 29754234
[TBL] [Abstract][Full Text] [Related]
40. CRISPR/Cas9 Technology as a Modern Genetic Manipulation Tool for Recapitulating of Neurodegenerative Disorders in Large Animal Models.
Barazesh M; Mohammadi S; Bahrami Y; Mokarram P; Morowvat MH; Saidijam M; Karimipoor M; Kavousipour S; Vosoughi AR; Khanaki K
Curr Gene Ther; 2021; 21(2):130-148. PubMed ID: 33319680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]